Document Detail


Azapropazone - its place in the management of rheumatoid conditions.
MedLine Citation:
PMID:  770085     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The authors review the trials carried out on azapropazone in rheumatoid arthritis and other rheumatoid conditions. They comment that in terms of efficacy azapropazone would appear to be a useful non-steroidal anti-inflammatory analgesic which compares favourably with other established antirheumatic agents against which it has been tested. Its main advantages are its low incidence of side-effects and the fact that in the majority of the trials reported azapropazone treatment was preferred by patients to that with other agents.
Authors:
P M Brooks; W W Buchanan
Related Documents :
3470495 - Oral ulcerations with use of hydrogen peroxide.
19203815 - Oral pyogenic granuloma: a review of 137 cases.
3733835 - Acute septic arthritis in infancy and childhood. 10 years' experience.
11361225 - Lessons from an international survey of paper cases of 10 real patients from an early a...
3878485 - Necrotizing scleritis. a clinico-pathologic study of 41 cases.
23413245 - Clinical semiology and neuroradiologic correlates of acute hypernatremic osmotic challe...
Publication Detail:
Type:  Clinical Trial; Journal Article; Review    
Journal Detail:
Title:  Current medical research and opinion     Volume:  4     ISSN:  0300-7995     ISO Abbreviation:  Curr Med Res Opin     Publication Date:  1976  
Date Detail:
Created Date:  1976-07-06     Completed Date:  1976-07-06     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0351014     Medline TA:  Curr Med Res Opin     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  94-100     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apazone / adverse effects,  therapeutic use*
Arthritis / drug therapy*
Arthritis, Rheumatoid / drug therapy
Clinical Trials as Topic
Drug Evaluation
Humans
Triazines / therapeutic use*
Chemical
Reg. No./Substance:
0/Triazines; 13539-59-8/Apazone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prolonged treatment with azapropazone.
Next Document:  A short-term double-blind trial of aerosol triamcinolone acetonide in steroid-dependent patients wit...